ASHLEY HENES: Open Payments
NPI 1831406594 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 27 payments from 12 companies in 2025. Trend: 2023 $814 · 2024 $668 · 2025 $677
Food & beverage: $578Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $139 |
| GENZYME CORPORATION | 4 | $131 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| ABBVIE INC. | 2 | $49 |
| Incyte Corporation | 2 | $48 |
| Organon LLC | 4 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Lilly USA, LLC | 1 | $27 |
| Journey Medical Corporation | 1 | $20 |
Products named: DUPIXENT, Bimzelx, SKYRIZI, OPZELURA, EBGLYSS, BLU-U, Winlevi, Varithena Administration Pack.
Industry payments across CO — which companies pay providers there.
